294 related articles for article (PubMed ID: 15796281)
1. Impact of nosocomial infection on cost of illness and length of stay in intensive care units.
Chen YY; Chou YC; Chou P
Infect Control Hosp Epidemiol; 2005 Mar; 26(3):281-7. PubMed ID: 15796281
[TBL] [Abstract][Full Text] [Related]
2. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
3. Incidence rate and variable cost of nosocomial infections in different types of intensive care units.
Chen YY; Wang FD; Liu CY; Chou P
Infect Control Hosp Epidemiol; 2009 Jan; 30(1):39-46. PubMed ID: 19046058
[TBL] [Abstract][Full Text] [Related]
4. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
5. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
6. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
7. Hospital costs associated with nosocomial infections in a pediatric intensive care unit.
Morillo-García Á; Aldana-Espinal JM; Olry de Labry-Lima A; Valencia-Martín R; López-Márquez R; Loscertales-Abril M; Conde-Herrera M
Gac Sanit; 2015; 29(4):282-7. PubMed ID: 25817552
[TBL] [Abstract][Full Text] [Related]
8. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Safdar N
Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
[TBL] [Abstract][Full Text] [Related]
9. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
Sheng WH; Chie WC; Chen YC; Hung CC; Wang JT; Chang SC
J Formos Med Assoc; 2005 May; 104(5):318-26. PubMed ID: 15959598
[TBL] [Abstract][Full Text] [Related]
10. [Impact on morbidity and costs of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in intensive care patients].
Larue A; Loos-Ayav C; Jay N; Commun N; Rabaud C; Bollaert PE
Presse Med; 2009 Jan; 38(1):25-33. PubMed ID: 18771897
[TBL] [Abstract][Full Text] [Related]
11. The outcome of extubation failure in a community hospital intensive care unit: a cohort study.
Seymour CW; Martinez A; Christie JD; Fuchs BD
Crit Care; 2004 Oct; 8(5):R322-7. PubMed ID: 15469575
[TBL] [Abstract][Full Text] [Related]
12. Factors related to hospital stay among patients with nosocomial infection acquired in the intensive care unit.
Olaechea PM; Ulibarrena MA; Alvarez-Lerma F; Insausti J; Palomar M; De la Cal MA;
Infect Control Hosp Epidemiol; 2003 Mar; 24(3):207-13. PubMed ID: 12683514
[TBL] [Abstract][Full Text] [Related]
13. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
Digiovine B; Chenoweth C; Watts C; Higgins M
Am J Respir Crit Care Med; 1999 Sep; 160(3):976-81. PubMed ID: 10471627
[TBL] [Abstract][Full Text] [Related]
14. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
15. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients.
Elward AM; Hollenbeak CS; Warren DK; Fraser VJ
Pediatrics; 2005 Apr; 115(4):868-72. PubMed ID: 15805357
[TBL] [Abstract][Full Text] [Related]
16. Costs of intravenous adverse drug events in academic and nonacademic intensive care units.
Nuckols TK; Paddock SM; Bower AG; Rothschild JM; Fairbanks RJ; Carlson B; Panzer RJ; Hilborne LH
Med Care; 2008 Jan; 46(1):17-24. PubMed ID: 18162851
[TBL] [Abstract][Full Text] [Related]
17. Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change.
Jain M; Miller L; Belt D; King D; Berwick DM
Qual Saf Health Care; 2006 Aug; 15(4):235-9. PubMed ID: 16885246
[TBL] [Abstract][Full Text] [Related]
18. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
[TBL] [Abstract][Full Text] [Related]
19. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
Ben-David D; Novikov I; Mermel LA
Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
[TBL] [Abstract][Full Text] [Related]
20. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
